Music-4-MS: A 12-week music-based program to support thinking skills in people with MS

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This feasibility study tests a 12-week music-based eHealth intervention called Music-4-MS for adults with multiple sclerosis. The approach uses music training and listening to engage multiple senses with the goal of supporting cognitive and emotional well-being. Researchers will assess practicality, engagement, and preliminary effects on cognition and mood to inform future larger trials. Participants must have MS, self-reported cognitive issues, and internet access to participate. The study is led by the University of Texas at Austin with collaboration from the National Institute of Nursing Research.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosed with multiple sclerosis (relapsing remitting, secondary progressive, primary progressive)
* Diagnosed more than 6 months prior to starting study
* Self-reported cognitive impairment as assessed by having at leased 5 problems "sometimes" or more often on the Perceived Deficits Questionnaire
* Read, write, and understand English
* Access to internet

Exclusion Criteria:

* Diagnosed with another neurological condition that causes cognitive impairment
* MS exacerbation within the last 30 days
* Professional musician (primary source of income)

Where it's running

• University of Texas at Austin
  Austin, Texas, United States Recruiting

Study contacts

• Principal investigator: Carolyn Phillips, PhD — University of Texas at Austin
• Study coordinator: Carolyn Phillips, PhD, RN
• Email: carolyn.phillips@nursing.utexas.edu
• Phone: 512-475-7039

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Comparing Rituximab and Ocrelizumab for Treating Relapsing Multiple Sclerosis

  This study is testing if rituximab works just as well as ocrelizumab for treating relapsing multiple sclerosis in adults.

  Recruiting Phase 3 Amsterdam UMC, location VUmc · Amsterdam · NCT05834855

• Identifying biomarkers for autoimmune diseases affecting the nervous system

  This study is trying to find specific markers in the blood of people with autoimmune diseases affecting the nervous system, like Multiple Sclerosis, to help with early diagnosis and better treatment options.

  Recruiting Tongji Hospital · Wuhan · NCT06502015

• Using CT103A cells to treat autoimmune diseases of the nervous system

  This study is testing if a new treatment using CT103A cells can help people with certain autoimmune diseases affecting the nervous system feel better.

  Recruiting Early Phase 1 Tongji Hospital · Wuhan, Hubei · NCT04561557

• ETHY-001 safety and activity in Thyroid Eye Disease (TED)

  This study tests ETHY-001 versus placebo to see if it is safe, tolerable, and shows activity in people with thyroid eye disease.

  Recruiting at 2 sites Phase 1 Ethyreal Bio, Inc. · Orland Park, Illinois and 2 other locations · NCT07885605

• AMX0035 in adults with Type 1 Diabetes

  This study tests whether 24 weeks of the oral medication AMX0035 help improves metabolic health in adults with Type 1 Diabetes compared with a placebo.

  Recruiting Phase 2 University of Washington · Seattle, Washington and 1 other locations · NCT07699380

• Treatment of generalized myasthenia gravis with a new CAR-T therapy

  This study is testing a new CAR-T therapy to see if it can safely help adults with generalized myasthenia gravis feel better.

  Recruiting at 14 sites Phase 1 Gilead Sciences · Los Angeles, California and 13 other locations · NCT06626919

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.